Cargando…

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Clostridium difficile causes antibiotic-associated diarrhea and pseudomembraneous colitis and is responsible for a large and increasing fraction of hospital-acquired infections. Fecal microbiota transplantation (FMT) is an alternate treatment option for recurrent C. difficile infection (RCDI) refrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yang, Garg, Shashank, Girotra, Mohit, Maddox, Cynthia, von Rosenvinge, Erik C., Dutta, Anand, Dutta, Sudhir, Fricke, W. Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841263/
https://www.ncbi.nlm.nih.gov/pubmed/24303043
http://dx.doi.org/10.1371/journal.pone.0081330
_version_ 1782292757221474304
author Song, Yang
Garg, Shashank
Girotra, Mohit
Maddox, Cynthia
von Rosenvinge, Erik C.
Dutta, Anand
Dutta, Sudhir
Fricke, W. Florian
author_facet Song, Yang
Garg, Shashank
Girotra, Mohit
Maddox, Cynthia
von Rosenvinge, Erik C.
Dutta, Anand
Dutta, Sudhir
Fricke, W. Florian
author_sort Song, Yang
collection PubMed
description Clostridium difficile causes antibiotic-associated diarrhea and pseudomembraneous colitis and is responsible for a large and increasing fraction of hospital-acquired infections. Fecal microbiota transplantation (FMT) is an alternate treatment option for recurrent C. difficile infection (RCDI) refractory to antibiotic therapy. It has recently been discussed favorably in the clinical and scientific communities and is receiving increasing public attention. However, short- and long-term health consequences of FMT remain a concern, as the effects of the transplanted microbiota on the patient remain unknown. To shed light on microbial events associated with RCDI and treatment by FMT, we performed fecal microbiota analysis by 16S rRNA gene amplicon pyrosequencing of 14 pairs of healthy donors and RCDI patients treated successfully by FMT. Post-FMT patient and healthy donor samples collected up to one year after FMT were studied longitudinally, including one post-FMT patient with antibiotic-associated relapse three months after FMT. This analysis allowed us not only to confirm prior reports that RCDI is associated with reduced diversity and compositional changes in the fecal microbiota, but also to characterize previously undocumented post-FMT microbiota dynamics. Members of the Streptococcaceae, Enterococcaceae, or Enterobacteriaceae were significantly increased and putative butyrate producers, such as Lachnospiraceae and Ruminococcaceae were significantly reduced in samples from RCDI patients before FMT as compared to post-FMT patient and healthy donor samples. RCDI patient samples showed more case-specific variations than post-FMT patient and healthy donor samples. However, none of the bacterial groups were invariably associated with RCDI or successful treatment by FMT. Overall microbiota compositions in post-FMT patients, specifically abundances of the above-mentioned Firmicutes, continued to change for at least 16 weeks after FMT, suggesting that full microbiota recovery from RCDI may take much longer than expected based on the disappearance of diarrheal symptoms immediately after FMT.
format Online
Article
Text
id pubmed-3841263
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38412632013-12-03 Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Song, Yang Garg, Shashank Girotra, Mohit Maddox, Cynthia von Rosenvinge, Erik C. Dutta, Anand Dutta, Sudhir Fricke, W. Florian PLoS One Research Article Clostridium difficile causes antibiotic-associated diarrhea and pseudomembraneous colitis and is responsible for a large and increasing fraction of hospital-acquired infections. Fecal microbiota transplantation (FMT) is an alternate treatment option for recurrent C. difficile infection (RCDI) refractory to antibiotic therapy. It has recently been discussed favorably in the clinical and scientific communities and is receiving increasing public attention. However, short- and long-term health consequences of FMT remain a concern, as the effects of the transplanted microbiota on the patient remain unknown. To shed light on microbial events associated with RCDI and treatment by FMT, we performed fecal microbiota analysis by 16S rRNA gene amplicon pyrosequencing of 14 pairs of healthy donors and RCDI patients treated successfully by FMT. Post-FMT patient and healthy donor samples collected up to one year after FMT were studied longitudinally, including one post-FMT patient with antibiotic-associated relapse three months after FMT. This analysis allowed us not only to confirm prior reports that RCDI is associated with reduced diversity and compositional changes in the fecal microbiota, but also to characterize previously undocumented post-FMT microbiota dynamics. Members of the Streptococcaceae, Enterococcaceae, or Enterobacteriaceae were significantly increased and putative butyrate producers, such as Lachnospiraceae and Ruminococcaceae were significantly reduced in samples from RCDI patients before FMT as compared to post-FMT patient and healthy donor samples. RCDI patient samples showed more case-specific variations than post-FMT patient and healthy donor samples. However, none of the bacterial groups were invariably associated with RCDI or successful treatment by FMT. Overall microbiota compositions in post-FMT patients, specifically abundances of the above-mentioned Firmicutes, continued to change for at least 16 weeks after FMT, suggesting that full microbiota recovery from RCDI may take much longer than expected based on the disappearance of diarrheal symptoms immediately after FMT. Public Library of Science 2013-11-26 /pmc/articles/PMC3841263/ /pubmed/24303043 http://dx.doi.org/10.1371/journal.pone.0081330 Text en © 2013 Song et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Song, Yang
Garg, Shashank
Girotra, Mohit
Maddox, Cynthia
von Rosenvinge, Erik C.
Dutta, Anand
Dutta, Sudhir
Fricke, W. Florian
Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
title Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
title_full Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
title_fullStr Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
title_full_unstemmed Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
title_short Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
title_sort microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent clostridium difficile infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841263/
https://www.ncbi.nlm.nih.gov/pubmed/24303043
http://dx.doi.org/10.1371/journal.pone.0081330
work_keys_str_mv AT songyang microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT gargshashank microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT girotramohit microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT maddoxcynthia microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT vonrosenvingeerikc microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT duttaanand microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT duttasudhir microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection
AT frickewflorian microbiotadynamicsinpatientstreatedwithfecalmicrobiotatransplantationforrecurrentclostridiumdifficileinfection